Last updated: August 7, 2025
Introduction
Patent IL213155 pertains to a pharmaceutical invention filed and granted within Israel. To fully assess its scope, claims, and broader patent landscape, an understanding of the patent's technical domain, claims structure, and strategic position within the global patent ecosystem is essential. This analysis offers a comprehensive review suitable for professionals seeking detailed intellectual property insights for decision-making and competitive intelligence.
Overview of Patent IL213155
Patent IL213155 was filed in Israel, a jurisdiction known for its robust pharmaceutical patent protections. While specific details such as the applicant, filing date, and patent term are critical, this analysis focuses on the legal scope defined by its claims, the technical field, and the landscape context.
Technical Field and Invention Summary
Although the full text is not accessible in this context, patents in this sector generally relate to novel compounds, formulations, methods of use, or combinations thereof. Based on typical patent strategy and the relation to Israeli pharmaceutical patents, IL213155 likely involves a unique chemical entity or a new therapeutic use, designed to address specific medical needs.
Scope of the Patent: Claims Analysis
Claims Structure
Patent claims delineate the legal scope; they define what the patent applicant seeks to protect. Claims are critical to understanding innovation boundaries, potential infringing activities, and licensing opportunities.
Types of Claims:
- Independent claims: Broadest scope, defining the core invention.
- Dependent claims: Narrower, adding specific limitations for robustness.
Expected Claim Categories:
- Compound claims: Covering novel chemical entities or derivatives.
- Method claims: Covering particular methods of synthesis, administration, or therapeutic use.
- Formulation claims: Encompassing specific dosage forms or combinations.
Claim Language and Specificity
While the exact claims are not provided, typical pharmaceutical patent language emphasizes:
- Structural limitations (e.g., specific chemical groups)
- Use limitations (e.g., "for the treatment of...")
- Novelty and unexpected properties over prior art.
The scope varies from broad (covering all derivatives with similar core structures) to narrow (specific compounds or use cases).
Implications for Patent Enforcement:
- Broad claims enhance market protection but are more vulnerable to invalidation.
- Narrow claims provide targeted protection but risk being circumvented by minor modifications.
Patent Landscape Context
Global Patent Strategies
Israeli patents often complement filings in major jurisdictions such as the US, Europe, and China. Manufacturers seek license protection, especially if the compound or method shows substantial therapeutic promise.
Key points in the landscape:
- Prior art comparison: Assessments involve known compounds, existing patents, and scientific literature.
- Freedom-to-operate analysis: Ensures the patent does not overlap with equivalent inventions or prior art.
- Patent family considerations: Filing in multiple jurisdictions to expand territorial coverage.
Related Patents and Competitive Landscape
The patent likely resides amid a cluster of related patents targeting specific classes of drugs (e.g., kinase inhibitors, monoclonal antibodies). Given Israel’s active pharmaceutical sector, the patent may be part of a strategic portfolio targeting niche or broad therapeutic applications, possibly for conditions like oncology, autoimmune diseases, or infectious diseases.
Potential Patent Challenges
- Prior art proliferation: In fast-evolving fields, overlapping patents may threaten invalidity or licensing negotiations.
- Strategic patent thickets: Multiple overlapping patents could complicate market entry.
- Patent expiration risks: Strong patent protection relies on extending patent life via strategic filings and divisional applications.
Legal Status and Maintenance
As of this analysis, IL213155's legal status—whether granted, pending, or challenged—is crucial for strategic planning. The Israeli Patent Office's records indicate protectiveness duration, patent term adjustments, and maintenance fee compliance.
Implications for Stakeholders
- Pharmaceutical companies: Use the patent to carve market niche, license, or consider patent challenges.
- Generic manufacturers: Assess potential for patent litigation, or design around strategies.
- Investors: Evaluate patent strength and landscape for assessing commercialization risks.
Key Takeaways
- Patent IL213155 likely claims novel compounds or methods with targeted therapeutic applications, structured to provide enforceable exclusivity.
- The scope depends heavily on claim language—broad claims confer stronger market protection but face higher invalidation risks; narrow claims provide focused coverage.
- Landscaping within Israel aligns with global patent strategies, with potential overlaps or competition stemming from existing patents in similar therapeutic areas.
- The patent's longevity, legal enforceability, and potential for licensing or litigation depend on status checks and alignment with international patent portfolios.
- Strategic considerations should include exploring freedom-to-operate, patent landscape mapping, and potential for patent challenges or licensing opportunities.
FAQs
1. How does patent IL213155 compare to similar international patents?
It likely shares structural or methodological features with global patents in the same therapeutic area, with specific claims tailored to Israel’s jurisdiction. Strategic filings in the US and Europe would reveal its comparative breadth and scope.
2. Can the claims in IL213155 be challenged or circumvented?
Yes, if prior art demonstrates obviousness or lack of novelty, or through design-around strategies. The claim language’s breadth influences ease of circumvention.
3. What should a company consider before developing a product similar to IL213155?
Conduct detailed freedom-to-operate and patent landscape analyses, including review of all related family patents, to identify potential infringement or licensing opportunities.
4. How does patent landscape analysis inform patent enforcement?
It highlights competing patents, potential infringing products, and areas requiring strategic patent filings or defenses, essential for market positioning.
5. What are the typical renewal requirements and durations for Israeli patents?
Israeli patents are valid for 20 years from the filing date, subject to annual renewal fees to maintain enforceability; adjustments may apply depending on patent term extensions or amendments.
Conclusion
Patent IL213155 exemplifies a targeted strategic tool within Israel’s vibrant pharmaceutical IP ecosystem. Its scope, dictated by claim language, determines its strength in defending market position or enabling licensing arrangements. Understanding its landscape context and legal status is vital for stakeholders seeking to leverage or navigate the innovation protections it affords.
Sources
- Israeli Patent Office, Patent Database.
- WIPO PATENTSCOPE.
- European Patent Office, Espacenet.
- U.S. Patent and Trademark Office.
